| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.
|
Lancet
|
2006
|
31.79
|
|
2
|
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
|
BMJ
|
2011
|
29.14
|
|
3
|
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.
|
Lancet
|
2002
|
16.56
|
|
4
|
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.
|
Ann Intern Med
|
2011
|
15.02
|
|
5
|
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
|
Lancet
|
2009
|
14.01
|
|
6
|
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study.
|
BMJ
|
2008
|
11.08
|
|
7
|
Mendelian randomization: using genes as instruments for making causal inferences in epidemiology.
|
Stat Med
|
2008
|
9.39
|
|
8
|
Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy.
|
Lancet
|
2005
|
7.89
|
|
9
|
Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.
|
Lancet
|
2010
|
6.02
|
|
10
|
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals.
|
AIDS
|
2010
|
5.85
|
|
11
|
A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints.
|
Stat Med
|
2006
|
5.43
|
|
12
|
When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.
|
Ann Intern Med
|
2011
|
5.35
|
|
13
|
Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America.
|
Clin Infect Dis
|
2005
|
5.20
|
|
14
|
HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.
|
Lancet
|
2006
|
5.00
|
|
15
|
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies.
|
AIDS
|
2007
|
4.31
|
|
16
|
Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials.
|
Ann Intern Med
|
2012
|
3.63
|
|
17
|
NHS waiting lists and evidence of national or local failure: analysis of health service data.
|
BMJ
|
2003
|
3.60
|
|
18
|
The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study.
|
Am J Epidemiol
|
2007
|
3.40
|
|
19
|
Secular trends in mortality by stroke subtype in the 20th century: a retrospective analysis.
|
Lancet
|
2002
|
3.29
|
|
20
|
A unification of models for meta-analysis of diagnostic accuracy studies.
|
Biostatistics
|
2006
|
3.23
|
|
21
|
Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review.
|
BMJ
|
2006
|
2.95
|
|
22
|
Using multiple genetic variants as instrumental variables for modifiable risk factors.
|
Stat Methods Med Res
|
2011
|
2.83
|
|
23
|
Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study.
|
AIDS
|
2010
|
2.66
|
|
24
|
A critical evaluation of statistical approaches to examining the role of growth trajectories in the developmental origins of health and disease.
|
Int J Epidemiol
|
2013
|
2.47
|
|
25
|
Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study.
|
BMJ
|
2005
|
2.43
|
|
26
|
Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials.
|
Lancet
|
2011
|
2.35
|
|
27
|
Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy.
|
Stat Med
|
2004
|
2.26
|
|
28
|
Was the economic crisis 1997-1998 responsible for rising suicide rates in East/Southeast Asia? A time-trend analysis for Japan, Hong Kong, South Korea, Taiwan, Singapore and Thailand.
|
Soc Sci Med
|
2009
|
2.18
|
|
29
|
Strategies for multiple imputation in longitudinal studies.
|
Am J Epidemiol
|
2010
|
2.15
|
|
30
|
Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009.
|
AIDS
|
2013
|
2.11
|
|
31
|
An empirical comparison of methods for meta-analysis of diagnostic accuracy showed hierarchical models are necessary.
|
J Clin Epidemiol
|
2008
|
2.07
|
|
32
|
Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa.
|
J Acquir Immune Defic Syndr
|
2012
|
2.03
|
|
33
|
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.
|
Clin Infect Dis
|
2009
|
1.86
|
|
34
|
Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa.
|
PLoS One
|
2010
|
1.84
|
|
35
|
Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies.
|
Antivir Ther
|
2008
|
1.83
|
|
36
|
Instrumental variable estimation of causal risk ratios and causal odds ratios in Mendelian randomization analyses.
|
Am J Epidemiol
|
2011
|
1.79
|
|
37
|
Systematic review: accuracy of anti-citrullinated Peptide antibodies for diagnosing rheumatoid arthritis.
|
Ann Intern Med
|
2010
|
1.78
|
|
38
|
Opportunistic and systematic screening for chlamydia: a study of consultations by young adults in general practice.
|
Br J Gen Pract
|
2006
|
1.75
|
|
39
|
Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent data.
|
J Clin Epidemiol
|
2005
|
1.72
|
|
40
|
An internationally generalizable risk index for mortality after one year of antiretroviral therapy.
|
AIDS
|
2013
|
1.64
|
|
41
|
Oxycodone for cancer-related pain: meta-analysis of randomized controlled trials.
|
Arch Intern Med
|
2006
|
1.62
|
|
42
|
The effect of exercise in clinically depressed adults: systematic review and meta-analysis of randomized controlled trials.
|
J Clin Psychiatry
|
2010
|
1.61
|
|
43
|
Partner notification of chlamydia infection in primary care: randomised controlled trial and analysis of resource use.
|
BMJ
|
2005
|
1.55
|
|
44
|
Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America.
|
AIDS
|
2015
|
1.44
|
|
45
|
Association of childhood socioeconomic position with cause-specific mortality in a prospective record linkage study of 1,839,384 individuals.
|
Am J Epidemiol
|
2006
|
1.43
|
|
46
|
The association between BMI and mortality using offspring BMI as an indicator of own BMI: large intergenerational mortality study.
|
BMJ
|
2009
|
1.43
|
|
47
|
Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis.
|
Cancer Causes Control
|
2011
|
1.43
|
|
48
|
Nutritional interventions and outcome in patients with cancer or preinvasive lesions: systematic review.
|
J Natl Cancer Inst
|
2006
|
1.39
|
|
49
|
Biases in Randomized Trials: A Conversation Between Trialists and Epidemiologists.
|
Epidemiology
|
2017
|
1.38
|
|
50
|
Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation.
|
Syst Rev
|
2014
|
1.36
|
|
51
|
Selenium and prostate cancer: systematic review and meta-analysis.
|
Am J Clin Nutr
|
2012
|
1.32
|
|
52
|
Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.
|
AIDS
|
2009
|
1.32
|
|
53
|
The evolution of the epidemic of charcoal-burning suicide in Taiwan: a spatial and temporal analysis.
|
PLoS Med
|
2010
|
1.32
|
|
54
|
Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies.
|
Arterioscler Thromb Vasc Biol
|
2005
|
1.31
|
|
55
|
Joint modelling rationale for chained equations.
|
BMC Med Res Methodol
|
2014
|
1.28
|
|
56
|
Why the Cochrane risk of bias tool should not include funding source as a standard item.
|
Cochrane Database Syst Rev
|
2013
|
1.24
|
|
57
|
Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study.
|
BMJ
|
2013
|
1.22
|
|
58
|
How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta-analysis?
|
Am J Epidemiol
|
2008
|
1.20
|
|
59
|
Correction: reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses.
|
Ann Intern Med
|
2008
|
1.17
|
|
60
|
The impact of CFS/ME on employment and productivity in the UK: a cross-sectional study based on the CFS/ME national outcomes database.
|
BMC Health Serv Res
|
2011
|
1.15
|
|
61
|
Differences in access and patient outcomes across antiretroviral treatment clinics in the Free State province: a prospective cohort study.
|
S Afr Med J
|
2010
|
1.15
|
|
62
|
Vulvovaginal-swab or first-catch urine specimen to detect Chlamydia trachomatis in women in a community setting?
|
J Clin Microbiol
|
2006
|
1.14
|
|
63
|
Geography of suicide in Taiwan: spatial patterning and socioeconomic correlates.
|
Health Place
|
2011
|
1.14
|
|
64
|
Unidentified Chronic Fatigue Syndrome/myalgic encephalomyelitis (CFS/ME) is a major cause of school absence: surveillance outcomes from school-based clinics.
|
BMJ Open
|
2011
|
1.13
|
|
65
|
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.
|
AIDS
|
2012
|
1.11
|
|
66
|
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.
|
Int J Epidemiol
|
2012
|
1.11
|
|
67
|
'Hidden' suicides amongst deaths certified as undetermined intent, accident by pesticide poisoning and accident by suffocation in Taiwan.
|
Soc Psychiatry Psychiatr Epidemiol
|
2009
|
1.09
|
|
68
|
A review identifies and classifies reasons for ordering diagnostic tests.
|
J Clin Epidemiol
|
2007
|
1.09
|
|
69
|
An atlas of suicide mortality: England and Wales, 1988-1994.
|
Health Place
|
2007
|
1.07
|
|
70
|
Social network analysis of childhood and youth physical activity: a systematic review.
|
Am J Prev Med
|
2012
|
1.06
|
|
71
|
Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.
|
J Acquir Immune Defic Syndr
|
2009
|
1.04
|
|
72
|
Factors associated with the decline in suicide by pesticide poisoning in Taiwan: a time trend analysis, 1987-2010.
|
Clin Toxicol (Phila)
|
2012
|
1.02
|
|
73
|
Inference from genome-wide association studies using a novel Markov model.
|
Genet Epidemiol
|
2008
|
1.01
|
|
74
|
Equity of access to specialist chronic fatigue syndrome (CFS/ME) services in England (2008-2010): a national survey and cross-sectional study.
|
BMJ Open
|
2012
|
1.00
|
|
75
|
A sequential Cox approach for estimating the causal effect of treatment in the presence of time-dependent confounding applied to data from the Swiss HIV Cohort Study.
|
Stat Med
|
2010
|
1.00
|
|
76
|
Chronic disabling fatigue at age 13 and association with family adversity.
|
Pediatrics
|
2012
|
0.99
|
|
77
|
Ongoing monitoring of data clustering in multicenter studies.
|
BMC Med Res Methodol
|
2012
|
0.98
|
|
78
|
The double jeopardy of clustered measurement and cluster randomisation.
|
BMJ
|
2009
|
0.98
|
|
79
|
Severity of bias of a simple estimator of the causal odds ratio in Mendelian randomization studies.
|
Stat Med
|
2012
|
0.97
|
|
80
|
'You can't tell by looking': pilot study of a community-based intervention to detect asymptomatic sexually transmitted infections.
|
Int J STD AIDS
|
2003
|
0.97
|
|
81
|
A contemporary validation of the Reeder Stress Inventory.
|
Br J Health Psychol
|
2003
|
0.97
|
|
82
|
Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study.
|
J Acquir Immune Defic Syndr
|
2011
|
0.97
|
|
83
|
A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men.
|
Int J Epidemiol
|
2007
|
0.96
|
|
84
|
Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality.
|
AIDS
|
2015
|
0.95
|
|
85
|
The geography of despair among 15-44-year-old men in England and Wales: putting suicide on the map.
|
J Epidemiol Community Health
|
2006
|
0.94
|
|
86
|
Graphical presentation of diagnostic information.
|
BMC Med Res Methodol
|
2008
|
0.94
|
|
87
|
Associations of different phenotypes of wheezing illness in early childhood with environmental variables implicated in the aetiology of asthma.
|
PLoS One
|
2012
|
0.91
|
|
88
|
How to apply the results of a research paper on diagnosis to your patient.
|
JRSM Short Rep
|
2013
|
0.91
|
|
89
|
Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?
|
AIDS
|
2008
|
0.91
|
|
90
|
Estimating the effect of cardiovascular risk factors on all-cause mortality and incidence of coronary heart disease using G-estimation: the atherosclerosis risk in communities study.
|
Am J Epidemiol
|
2002
|
0.91
|
|
91
|
The publication process itself was the major cause of publication bias in genetic epidemiology.
|
J Clin Epidemiol
|
2006
|
0.89
|
|
92
|
Genome-wide prediction of childhood asthma and related phenotypes in a longitudinal birth cohort.
|
J Allergy Clin Immunol
|
2012
|
0.89
|
|
93
|
A comparison of socio-demographic and psychological factors between patients consenting to randomisation and those selecting treatment (the ProtecT study).
|
Contemp Clin Trials
|
2006
|
0.89
|
|
94
|
Cause-specific hospital admission and mortality among working men: association with socioeconomic circumstances in childhood and adult life, and the mediating role of daily stress.
|
Eur J Public Health
|
2005
|
0.89
|
|
95
|
Combining individual and ecological data to determine compositional and contextual socio-economic risk factors for suicide.
|
Soc Sci Med
|
2006
|
0.88
|
|
96
|
Lack of identification in semiparametric instrumental variable models with binary outcomes.
|
Am J Epidemiol
|
2014
|
0.88
|
|
97
|
Examination of the relationship between variation at 17q21 and childhood wheeze phenotypes.
|
J Allergy Clin Immunol
|
2012
|
0.88
|
|
98
|
Socioeconomic inequalities in health.
|
BMJ
|
2007
|
0.86
|
|
99
|
Using bivariate models to understand between- and within-cluster regression coefficients, with application to twin data.
|
Biometrics
|
2006
|
0.85
|
|
100
|
Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration.
|
J Acquir Immune Defic Syndr
|
2015
|
0.85
|
|
101
|
Insurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies.
|
AIDS
|
2013
|
0.84
|
|
102
|
Frequent job change and associated health.
|
Soc Sci Med
|
2003
|
0.84
|
|
103
|
Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis.
|
AIDS
|
2013
|
0.83
|
|
104
|
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.
|
Clin Infect Dis
|
2015
|
0.83
|
|
105
|
Is MRI better than CT for detecting a vascular component to dementia? A systematic review and meta-analysis.
|
BMC Neurol
|
2012
|
0.82
|
|
106
|
Screening for chlamydia.
|
Lancet
|
2005
|
0.82
|
|
107
|
Temporal growth and geographic variation in the use of laboratory tests by NHS general practices: using routine data to identify research priorities.
|
Br J Gen Pract
|
2013
|
0.81
|
|
108
|
Stent-related ureteric obstruction in paediatric renal transplantation.
|
Pediatr Nephrol
|
2005
|
0.79
|
|
109
|
Comparison of secretory IgA and IgG isotype levels in palatal secretions of denture stomatitis patients with denture wearers having clinically healthy palates.
|
Eur J Prosthodont Restor Dent
|
2007
|
0.78
|
|
110
|
Sifting the evidence-what's wrong with significance tests?
|
Phys Ther
|
2001
|
0.76
|
|
111
|
Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
112
|
Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis.
|
AIDS
|
2016
|
0.75
|
|
113
|
N-3 polyunsaturated fatty acids and statins in heart failure.
|
Lancet
|
2009
|
0.75
|
|
114
|
Thighs and heart disease. Thighs and thresholds.
|
BMJ
|
2009
|
0.75
|
|
115
|
Industry, incidents and casualties in South West England: what is their relationship and are there social inequalities in their distribution?
|
Environ Geochem Health
|
2008
|
0.75
|
|
116
|
Grandparent donors in paediatric renal transplantation.
|
Pediatr Nephrol
|
2005
|
0.75
|
|
117
|
Using qualitative research to inform development of a diagnostic algorithm for UTI in children.
|
Fam Pract
|
2012
|
0.75
|
|
118
|
Development of a combined database for meta-epidemiological research.
|
Res Synth Methods
|
2011
|
0.75
|
|
119
|
Association Between Risk-of-Bias Assessments and Results of Randomized Trials in Cochrane Reviews: the ROBES Meta-Epidemiologic Study.
|
Am J Epidemiol
|
2017
|
0.75
|